122 related articles for article (PubMed ID: 2410415)
1. Anti-substance P anti-idiotypic antibodies. Characterization and biological activities.
Couraud JY; Escher E; Regoli D; Imhoff V; Rossignol B; Pradelles P
J Biol Chem; 1985 Aug; 260(16):9461-9. PubMed ID: 2410415
[TBL] [Abstract][Full Text] [Related]
2. Anti-substance P anti-idiotypic antibodies modulate the secretory process in the rat parotid gland in vitro.
Maillet S; Imhoff V; Rossignol B; Grassi J; Pradelles P; Couraud JY
Eur J Pharmacol; 1990 Oct; 187(3):357-67. PubMed ID: 1705891
[TBL] [Abstract][Full Text] [Related]
3. Development of an anti-idiotypic antibody that blocks substance P primary antibodies and substance P membrane binding.
Swenberg ML; Buck SH; Lovenberg W
Brain Res; 1987 Aug; 417(1):131-8. PubMed ID: 2441817
[TBL] [Abstract][Full Text] [Related]
4. Use of anti-idiotypic antibodies as probes for in vitro and in vivo identification of substance P receptor.
Couraud JY; Maillet S; Conrath M; Calvino B; Pradelles P
Mol Chem Neuropathol; 1990 Jan; 12(1):71-82. PubMed ID: 1703763
[TBL] [Abstract][Full Text] [Related]
5. Relative activities of substance P-related peptides in the guinea-pig ileum and rat parotid gland, in vitro.
Gater PR; Jordan CC; Owen DG
Br J Pharmacol; 1982 Feb; 75(2):341-51. PubMed ID: 6194840
[TBL] [Abstract][Full Text] [Related]
6. Possible existence of a new tachykinin receptor subtype in the guinea pig ileum.
Petitet F; Saffroy M; Torrens Y; Lavielle S; Chassaing G; Loeuillet D; Glowinski J; Beaujouan JC
Peptides; 1992; 13(2):383-8. PubMed ID: 1384010
[TBL] [Abstract][Full Text] [Related]
7. Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists.
Mizrahi J; Dion S; D'Orléans-Juste P; Escher E; Drapeau G; Regoli D
Eur J Pharmacol; 1985 Nov; 118(1-2):25-36. PubMed ID: 2417867
[TBL] [Abstract][Full Text] [Related]
8. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.
Maggi CA; Patacchini R; Meini S; Quartara L; Sisto A; Potier E; Giuliani S; Giachetti A
Br J Pharmacol; 1994 May; 112(1):150-60. PubMed ID: 7518302
[TBL] [Abstract][Full Text] [Related]
9. [pGlu6,Pro9]SP6-11, a selective agonist for the substance P P-receptor subtype.
Laufer R; Gilon C; Chorev M; Selinger Z
J Med Chem; 1986 Jul; 29(7):1284-8. PubMed ID: 2433445
[TBL] [Abstract][Full Text] [Related]
10. The possible existence of multiple receptors for substance P.
Lee CM; Iversen LL; Hanley MR; Sandberg BE
Naunyn Schmiedebergs Arch Pharmacol; 1982 Mar; 318(4):281-7. PubMed ID: 6176885
[TBL] [Abstract][Full Text] [Related]
11. Novel selective agonists and antagonists confirm neurokinin NK1 receptors in guinea-pig vas deferens.
Hall JM; Morton IK
Br J Pharmacol; 1991 Feb; 102(2):511-7. PubMed ID: 1707714
[TBL] [Abstract][Full Text] [Related]
12. [Pro9]SP and [pGlu6, Pro9]SP(6-11) interact with two different receptors in the guinea-pig ileum as demonstrated with new SP antagonists.
Chassaing G; Lavielle S; Brunissen A; Carruette A; Garret C; Petitet F; Saffroy M; Beaujouan JC; Torrens Y; Glowinski J
Neuropeptides; 1992 Oct; 23(2):73-9. PubMed ID: 1280787
[TBL] [Abstract][Full Text] [Related]
13. Analogues of substance P. Peptides containing D-amino acid residues in various positions of substance P and displaying agonist or receptor selective antagonist effects.
Dutta AS; Gormley JJ; Graham AS; Briggs I; Growcott JW; Jamieson A
J Med Chem; 1986 Jul; 29(7):1163-71. PubMed ID: 2433442
[TBL] [Abstract][Full Text] [Related]
14. A synthetic glycopeptide of substance P analogue (SP6-11) with enhanced NK-1 receptor specificity.
Haro I; Busquets MA; Torres JL; Valencia G; Garcia-Anton JM; Reig F
J Pharm Sci; 1990 Jan; 79(1):74-6. PubMed ID: 1690289
[TBL] [Abstract][Full Text] [Related]
15. Species differences between [3H] substance P binding in rat and guinea-pig shown by the use of peptide agonists and antagonists.
Fardin V; Garret C
Eur J Pharmacol; 1991 Aug; 201(2-3):231-4. PubMed ID: 1724651
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of tachykinin-stimulated inositol phospholipid hydrolysis in peripheral tissues.
Suman-Chauhan N; Guard S; Williams BJ; Watling KJ
Br J Pharmacol; 1990 Dec; 101(4):1001-5. PubMed ID: 1707702
[TBL] [Abstract][Full Text] [Related]
17. Functional evidence for NO-synthase activation by substance P through a mechanism not involving classical tachykinin receptors in guinea-pig ileum in vitro.
Garcia-Villar R; Dupuis C; Martinolle JP; Fioramonti J; Buéno L
Br J Pharmacol; 1996 Jul; 118(5):1253-61. PubMed ID: 8818351
[TBL] [Abstract][Full Text] [Related]
18. FR 113680: a novel tripeptide substance P antagonist with NK1 receptor selectivity.
Morimoto H; Murai M; Maeda Y; Hagiwara D; Miyake H; Matsuo M; Fujii T
Br J Pharmacol; 1992 May; 106(1):123-6. PubMed ID: 1380378
[TBL] [Abstract][Full Text] [Related]
19. Specific recognition of SP or NKB receptors by analogues of SP substituted at positions 8 and 9.
Lavielle S; Chassaing G; Julien S; Marquet A; Bergström L; Beaujouan JC; Torrens Y; Glowinski J
Eur J Pharmacol; 1986 Jun; 125(3):461-2. PubMed ID: 2426130
[No Abstract] [Full Text] [Related]
20. Pharmacological properties of a potent and selective nonpeptide substance P antagonist.
Garret C; Carruette A; Fardin V; Moussaoui S; Peyronel JF; Blanchard JC; Laduron PM
Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10208-12. PubMed ID: 1719549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
